Advertisement.

RCKT Projected Dividend Yield

Rocket Pharmaceuticals Inc ( NASDAQ : RCKT )

Rocket Pharmaceuticals, Inc. is a late-stage biotechnology company developing genetic therapies for complex and rare disorders. Its lentiviral vector-based gene therapies target hematologic diseases, including late-stage programs for Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency. The company also has in vivo adeno-associated virus programs in clinical and pre-clinical stages for Danon disease, Plakophilin-2 Arrhythmogenic Cardiomyopathy, and BAG3 Dilated Cardiomyopathy.

21 YEAR PERFORMANCE RESULTS

RCKT Dividend History Detail
RCKT Dividend News
RCKT Competitors News

# of Shares: 0

Closing Price: 6.33

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000